PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This week in PLoS Medicine: HIV resistance in women treated with nevirapine; Charging less for more effective treatments; Developing guidelines for better reporting

PLOS General

Read the new papers published in PLoS Medicine this week, including a Research Article that confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women, another Research Article that calculates the benefits of value-based insurance design, in which patients pay less for highly cost-effective services, and a Guidelines and Guidance piece that provides a substantial new resource for the developers of guidelines of the reporting of health research.

You can comment on, annotate, and rate this week’s PLoS Medicine articles and any of the others in the archive.

Back to top